Skip to main content

HubXchange

HubXChange logo

Advanced Therapies Xchange - San Diego - 2027

Page Banner 1

  1. Cell Therapy Development
    • Cell Therapy Development
    Poster Presentation: Translational challenges in predictive preclinical models
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
    Spotlight Presentation:
  3. Cell Therapy Manufacturing
    • Cell Therapy Manufacturing
    Poster Presentation: Automation and digital QA systems in cell therapy manufacturing
  4. Gene Therapy Manufacturing
    • Gene Therapy Manufacturing
    Intelligent commercial gene therapy manufacturing: Before and after product approval
  5. Gene Therapy Manufacturing
    • Gene Therapy Manufacturing
    Poster Presentation: Integration of digital systems and automation in vector manufacturing and QC
  6. Gene Therapy Development
    • Gene Therapy Development
    What are the most effective strategies to predict and mitigate immune responses to gene therapies, both in preclinical and early clinical stages?
  7. Cell Therapy Manufacturing
    • Cell Therapy Manufacturing
    Scaling cell therapy manufacturing without compromising quality: Rethinking compliance, digitalization, and GMP
  8. Cell Therapy Development
    • Cell Therapy Development
    Scaling up PSC-derived cell therapies from 2D to 3D
  9. Cell Therapy Manufacturing
    • Cell Therapy Manufacturing
    The factory of the future: Will cell therapy manufacturing be replaced, reinvented, or brought to the patient?
  10. Gene Therapy Development
    • Gene Therapy Development
    Engineering AAV gene therapy for human translation: Lessons on potency, biodistribution and immunogenicity from local delivery to the eye
  11. Gene Therapy Development
    • Gene Therapy Development
    How can we enhance AAV, LV, and non-viral delivery technologies to increase efficiency, tissue targeting, and reduce immunogenicity?
  12. Gene Therapy Manufacturing
    • Gene Therapy Manufacturing
    GMP-compliant viral vector production: scale-up, reproducibility, and quality control
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
    Afternoon Refreshments
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
    Morning Refreshments
  15. Cell Therapy Manufacturing
    • Cell Therapy Manufacturing
    Advancing CMC for autologous cell therapies: building robust, scalable platforms
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
    Evening Drinks Reception
  17. Gene Therapy Development
    • Gene Therapy Development
    Poster Presentation: How can circulating biomarkers, genomic integration assays, or functional assays better predict efficacy and long-term safety in patients?
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
    1-2-1 Meetings / Networking Break
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
    1-2-1 Meetings / Networking Break
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
    Spotlight Presentation:
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
    Networking Lunch
  22. Cell Therapy Development
    • Cell Therapy Development
    Potency and safety considerations for iPSC-derived cell products
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
    1-2-1 Meetings / Networking Break
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
    1-2-1 Meetings / Networking Break
  25. Gene Therapy Manufacturing
    • Gene Therapy Manufacturing
    Control strategy for replication competent AAV formation in AAV manufacturing
  26. Cell Therapy Development
    • Cell Therapy Development
    From Lab to Lot Release: Analytical readiness in centralized and decentralized cell and gene therapy manufacturing
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
    Opening Address & Keynote Presentation
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
    Registration
Search